Breast Surgery Practice Questions

Q: Which of the following are NOT associated with breast cancer?

Fibroadenoma, Moderate hyperplasia. To answer this question, we must categorize benign breast diseases based on their risk of progressing to malignancy, as defined by the **Dupont and Page classification**. ### **1. Why Option B is Correct** The question asks for conditions **NOT** associated with an increased risk of breast cancer. * **Fibroadenoma:** This is a benign fibroepithelial tumor. Simple fibroadenomas carry **no increased risk** (Relative Risk ≈ 1.0) of developing breast cancer. * **Moderate Hyperplasia (without atypia):** While "mild" hyperplasia has no risk, "moderate or florid" hyperplasia without atypia carries only a **slightly increased risk** (RR 1.5–2.0). In the context of NEET-PG, when compared to high-risk lesions like BRCA mutations or atypical hyperplasia, these are considered the "least associated" or clinically insignificant regarding cancer progression. ### **2. Analysis of Incorrect Options** * **Option A & D:** These include **BRCA 1 & BRCA 2** mutations, which are the strongest genetic risk factors for breast cancer (Lifetime risk up to 70-80%). **Apocrine metaplasia** (found in Option A) is a common component of fibrocystic change and carries no risk, but the presence of BRCA makes these options incorrect. * **Option C:** Includes **Atypical Ductal Hyperplasia (ADH)**. ADH is a high-risk precursor lesion with a Relative Risk of **4.0–5.0**. ### **3. NEET-PG High-Yield Pearls** * **No Increased Risk (RR 1.0):** Adenosis, duct ectasia, simple cysts, apocrine metaplasia, mild hyperplasia, and simple fibroadenoma. * **Slightly Increased Risk (RR 1.5–2.0):** Moderate/florid hyperplasia (without atypia), sclerosing adenosis, and complex sclerosing lesion (radial scar), papillomas. * **Moderately Increased Risk (RR 4.0–5.0):** Atypical Ductal Hyperplasia (ADH) and Atypical Lobular Hyperplasia (ALH). * **Highest Risk:** BRCA mutations, LCIS (Lobular Carcinoma in Situ), and DCIS (Ductal Carcinoma in Situ).

Q: Which quadrant of the breast is the least common site for cancer?

Lower Inner Quadrant. **Explanation:** The distribution of breast cancer is directly proportional to the volume of glandular (ductal and lobular) tissue present in each quadrant. The **Lower Inner Quadrant (LIQ)** contains the least amount of breast parenchyma compared to other regions, making it the least common site for primary breast malignancies (approximately 2–5%). **Analysis of Options:** * **Lower Inner Quadrant (Correct):** As mentioned, this area has the lowest density of terminal duct lobular units (TDLUs), the site where most cancers originate. * **Superior Outer Quadrant (Incorrect):** This is the **most common site** (approx. 50%) because it contains the largest volume of glandular tissue and extends into the axillary tail of Spence. * **Inferior Outer Quadrant (Incorrect):** This accounts for roughly 10% of cases, making it more common than the inner quadrants but less common than the upper outer quadrant. * **Subareolar/Central (Incorrect):** This region accounts for about 15–20% of cancers. Tumors here often present with nipple retraction or discharge. **High-Yield Clinical Pearls for NEET-PG:** 1. **Frequency Ranking:** Upper Outer (50%) > Central/Subareolar (15-20%) > Upper Inner (15%) > Lower Outer (10%) > **Lower Inner (2-5%)**. 2. **Prognosis:** Tumors in the **inner quadrants** (UIQ and LIQ) have a slightly higher risk of involving the **internal mammary lymph nodes**, which can sometimes lead to a worse prognosis due to "silent" metastasis compared to the more accessible axillary nodes. 3. **Multicentricity:** Breast cancer is often multicentric (multiple tumors in different quadrants), which is a key consideration when deciding between Breast Conserving Surgery (BCS) and Mastectomy.

Q: The Gail Model is used for risk assessment of which of the following?

Breast cancer. **Explanation:** The **Gail Model** (also known as the Breast Cancer Risk Assessment Tool) is a widely used clinical tool designed to estimate a woman's risk of developing **invasive breast cancer** over the next five years and over her lifetime (up to age 90). It utilizes specific personal and family history factors to calculate risk. **Why Breast Cancer is Correct:** The model incorporates key risk factors including: * Current age. * Age at menarche. * Age at first live birth. * Number of previous breast biopsies and presence of atypical hyperplasia. * Number of first-degree relatives with breast cancer. * Race/ethnicity. **Why Other Options are Incorrect:** * **Ovarian Cancer:** Risk is typically assessed using the **ROMA score** (Risk of Ovarian Malignancy Algorithm) or genetic testing for BRCA1/2 mutations. * **Prostate Cancer:** Screening and risk are primarily assessed via **PSA levels** and the **IPSS score** (for symptoms), not the Gail Model. * **Lung Cancer:** Risk is determined by smoking history (pack-years) and assessed using low-dose CT screening criteria (e.g., USPSTF guidelines). **High-Yield Clinical Pearls for NEET-PG:** * **Threshold for Intervention:** A 5-year risk score of **≥1.67%** is considered "high risk." In such patients, chemoprevention with Selective Estrogen Receptor Modulators (SERMs) like **Tamoxifen** or **Raloxifene** may be indicated. * **Limitations:** The Gail Model **underestimates** risk in women with a strong family history of paternal breast cancer or those with known **BRCA1/2 mutations**. For these patients, the **Claus Model** or **BRCAPRO** is preferred. * **Modified Gail Model:** This version is specifically validated for use in various ethnic groups, including Asian Americans.

Q: A 35-year-old premenopausal patient has recently developed a 1.5 cm sized pigmented lesion on her back. Which of the following forms of tissue diagnosis will you recommend for her?

Excision biopsy. **Explanation:** The clinical presentation of a new, pigmented lesion in a 35-year-old patient must be managed with a high index of suspicion for **Malignant Melanoma**. **1. Why Excision Biopsy is the Correct Choice:** For any suspicious pigmented lesion, the gold standard for diagnosis is an **Excisional Biopsy** with a narrow margin (typically 1–3 mm). The primary reason is that the prognosis and surgical management of melanoma are determined by the **Breslow Depth** (the vertical thickness of the tumor in millimeters). An excisional biopsy provides the pathologist with the entire architecture of the lesion, allowing for an accurate measurement of depth and ensuring no "sampling error" occurs. **2. Why Other Options are Incorrect:** * **Needle Biopsy (FNAC) & Trucut Biopsy (Options A & B):** These provide only cytological or small architectural samples. They are insufficient for determining the Breslow depth and have a high rate of false negatives in pigmented lesions. * **Incisional Biopsy (Option D):** This involves taking only a piece of the lesion. It is generally contraindicated for small pigmented lesions because it may miss the thickest part of the tumor (leading to understaging) and theoretically risks "seeding" or disrupting the local lymphatics, though the latter is debated. It is only reserved for very large lesions or those in cosmetically sensitive areas (e.g., face, subungual). **Clinical Pearls for NEET-PG:** * **Breslow Thickness:** The most important prognostic factor in cutaneous melanoma. * **ABCDE Criteria:** Used to identify suspicious lesions (Asymmetry, Border irregularity, Color variegation, Diameter >6mm, Evolving). * **Safety Margins:** Once melanoma is confirmed via excision biopsy, a **Wide Local Excision (WLE)** is performed with margins based on the Breslow depth (e.g., 1 cm margin for depth 2 mm).

Q: Which of the following is NOT related to Mondor's disease?

Variant of thrombophlebitis. **Explanation:** **Mondor’s Disease** is a rare, benign condition characterized by **superficial thrombophlebitis** of the subcutaneous veins of the breast and anterior chest wall. It most commonly involves the lateral thoracic, thoracoepigastric, or superior epigastric veins. 1. **Why Option C is the Correct Answer:** The question asks which is **NOT** related to Mondor's disease. However, based on standard medical definitions, Mondor's disease **is** a variant of thrombophlebitis. *Note: If the question asks for the "NOT" related option, there may be a typographical error in the provided key, as A, B, and D are all incorrect statements, while C is a true clinical fact about the disease.* 2. **Analysis of Other Options:** * **Option A (Lymphedema):** Mondor’s disease does not cause lymphedema. It is a venous pathology, not a lymphatic one. * **Option B (Risk factor for cancer):** Mondor’s disease is **not** a risk factor for breast cancer. It is a self-limiting, benign condition, though it can occasionally be associated with underlying malignancy in rare cases. * **Option D (Mastectomy):** Mastectomy is never indicated. The treatment is **conservative**, involving reassurance, warm compresses, and NSAIDs for pain relief. **Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Patients present with a sudden onset of a **painful, palpable "cord-like" structure** on the breast or chest wall. * **Skin Changes:** "Groove sign" or skin tethering may be seen when the arm is elevated. * **Etiology:** Often idiopathic but can follow trauma, vigorous exercise, or breast surgery. * **Management:** It is self-limiting and usually resolves spontaneously within 4 to 8 weeks. No anticoagulation is required.

Q: A 30-year-old female presents with complaints of cord-like structures on her arm and breast, with no history of injury or infection. These cords are best demonstrated on elevation of the hand. What is the most possible diagnosis?

Mondor's disease. **Explanation:** The clinical presentation of palpable, cord-like structures on the breast and arm that become more prominent upon limb elevation is pathognomonic for **Mondor’s Disease**. **1. Why Mondor’s Disease is Correct:** Mondor’s disease is a **superficial thrombophlebitis** affecting the veins of the breast and anterior chest wall (most commonly the lateral thoracic, thoracoepigastric, or superior epigastric veins). The "cord-like" feel represents the thrombosed vein. Elevating the arm stretches the skin over the vein, making the cord more visible—a classic clinical sign. It is usually self-limiting and managed with NSAIDs. **2. Why Other Options are Incorrect:** * **Poland Syndrome:** A congenital anomaly characterized by the unilateral absence of the pectoralis major muscle, often associated with syndactyly. It does not present with cord-like structures. * **Tietze Disease:** An inflammatory condition causing painful swelling of the costochondral junctions (rib cartilage). It presents as localized chest wall pain/swelling, not superficial venous cords. * **Duct Ectasia:** A benign condition involving dilation of the lactiferous ducts, typically presenting with nipple discharge (green/brown) and subareolar masses, not superficial chest wall findings. **3. NEET-PG High-Yield Pearls:** * **Triad of Veins:** Lateral thoracic, Thoracoepigastric, and Superior epigastric veins. * **Clinical Sign:** The "Iron Wire" or "Bowstring" sign (prominence on abduction/elevation of the arm). * **Etiology:** Often idiopathic, but can follow vigorous exercise, breast surgery, or trauma. * **Association:** While usually benign, in rare cases, it can be a marker for underlying breast malignancy; hence, a mammogram is often recommended in older patients.

Q: Which of the following conditions is NOT related to Aberrations of Normal Development and Involution (ANDI) of the breast?

Intraductal papilloma. **Explanation:** The concept of **ANDI (Aberrations of Normal Development and Involution)**, proposed by Hughes and Mansel, classifies benign breast disorders based on the normal physiological processes of the breast: development, cyclical change, and involution. It distinguishes between normal variations, minor aberrations, and true disease. **Why Intraductal Papilloma is the correct answer:** Intraductal papilloma is considered a **true neoplastic process** (a discrete benign tumor of the lactiferous ducts) rather than a deviation from normal physiological development or involution. Therefore, it does not fall under the ANDI classification. **Analysis of Incorrect Options:** * **Fibroadenoma (Option A):** This is an aberration of the **Development** phase (ages 15–25). It arises from the overgrowth of a single lobule. Giant fibroadenomas are considered "disease," while standard ones are "aberrations." * **Duct Ectasia (Option B):** This is an aberration of **Involution** (specifically stromal and ductal involution). It occurs when the subareolar ducts dilate and fill with debris, typically in the 50s. * **Cyclical Mastalgia (Option C):** This is an aberration of **Cyclical Changes** during the reproductive years. While mild tenderness is normal, severe cyclical pain is classified as an ANDI aberration. **NEET-PG High-Yield Pearls:** * **ANDI Categories:** 1. **Development (15–25 yrs):** Fibroadenoma, Adolescent hypertrophy. 2. **Cyclical Changes (Period of activity):** Cyclical mastalgia, Nodularity. 3. **Involution (35–55 yrs):** Cysts, Sclerosing adenosis, Duct ectasia, Periductal fibrosis. * **Clinical Note:** Intraductal papilloma is the most common cause of **bloody nipple discharge** from a single duct. * **Management:** Most ANDI conditions are managed conservatively once malignancy is ruled out (Triple Assessment).

Q: Which of the following is a risk factor for breast carcinoma in women?

Consumption of fatty food. **Explanation:** The correct answer is **A. Consumption of fatty food.** **1. Why "Consumption of fatty food" is correct:** Dietary fat intake is a recognized modifiable risk factor for breast carcinoma. High fat consumption leads to obesity, particularly in postmenopausal women. Adipose tissue contains the enzyme **aromatase**, which converts peripheral androgens into **estrone** (a type of estrogen). Since breast cancer is frequently hormone-dependent, increased cumulative exposure to estrogen promotes the proliferation of mammary epithelium, thereby increasing the risk of malignancy. **2. Why the other options are incorrect:** * **B. Early menopause:** This is a protective factor. **Late menopause** (after age 55) is the actual risk factor because it extends the duration of the "estrogen window." * **C. Smoking:** While smoking is a major risk factor for many cancers (lung, bladder, head, and neck), its direct causal link to breast cancer is less established compared to hormonal and genetic factors. * **D. Multiple sexual partners:** This is a risk factor for **Cervical Cancer** due to increased exposure to Human Papillomavirus (HPV), but it has no association with breast cancer. **3. NEET-PG High-Yield Clinical Pearls:** * **The "Estrogen Window" Concept:** Anything that increases the number of menstrual cycles (Early menarche 55y, Nulliparity) increases breast cancer risk. * **Protective Factors:** Early pregnancy (<20 years), breastfeeding, and regular physical exercise. * **Genetic Risk:** BRCA1 (Chromosome 17) and BRCA2 (Chromosome 13) are the most significant genetic mutations. * **Atypical Hyperplasia:** Finding atypical ductal or lobular hyperplasia on biopsy increases risk by 4–5 times.

Question 1

Which of the following are NOT associated with breast cancer?

Accepted Answer

Fibroadenoma, Moderate hyperplasia

Answer

BRCA 1 & BRCA 2, Apocrine metaplasia, Moderate hyperplasia

Answer

Atypical ductal hyperplasia, Moderate hyperplasia, Fibroadenoma

Answer

BRCA 1 & BRCA 2, Atypical ductal hyperplasia, Moderate hyperplasia

Question 2

Which quadrant of the breast is the least common site for cancer?

Accepted Answer

Lower Inner Quadrant

Answer

Superior Outer

Answer

Inferior Outer

Answer

Subareolar

Question 3

A 26-year-old breastfeeding woman presents with redness, pain around the nipple, and purulent discharge. Staphylococcus aureus was cultured from the discharge. Which of the following statements is true about the patient's condition?

Accepted Answer

This condition mostly occurs during the first month of breastfeeding.

Answer

NSAIDs are contraindicated in this condition.

Answer

The patient is suffering from periductal mastitis.

Answer

Breastfeeding is contraindicated.

Question 4

The Gail Model is used for risk assessment of which of the following?

Accepted Answer

Breast cancer

Answer

Ovarian cancer

Answer

Prostate cancer

Answer

Lung cancer

Question 5

A 42-year-old woman presents with a swollen, painful, erythematous left breast which does not respond to a 10-day course of oxacillin. Ultrasound reveals no abscess. What is the next step in management?

Accepted Answer

Biopsy the skin and parenchyma of the breast

Answer

Begin a 10-day course of vancomycin

Answer

Workup the patient for an immunosuppressive disease

Answer

Incision and drainage of the area

Question 6

A 35-year-old premenopausal patient has recently developed a 1.5 cm sized pigmented lesion on her back. Which of the following forms of tissue diagnosis will you recommend for her?

Accepted Answer

Excision biopsy

Answer

Needle biopsy

Answer

Trucut biopsy

Answer

Incisional biopsy

Question 7

Which of the following is NOT related to Mondor's disease?

Accepted Answer

Variant of thrombophlebitis

Answer

Lymphedema of upper limb

Answer

Risk factor for breast cancer

Answer

Mastectomy is the treatment of choice

Question 8

A 30-year-old female presents with complaints of cord-like structures on her arm and breast, with no history of injury or infection. These cords are best demonstrated on elevation of the hand. What is the most possible diagnosis?

Accepted Answer

Mondor's disease

Answer

Poland syndrome

Answer

Teitz disease

Answer

Duct ectasia

Question 9

Which of the following conditions is NOT related to Aberrations of Normal Development and Involution (ANDI) of the breast?

Accepted Answer

Intraductal papilloma

Answer

Fibroadenoma

Answer

Duct ectasia

Answer

Cyclical mastalgia

Question 10

Which of the following is a risk factor for breast carcinoma in women?

Accepted Answer

Consumption of fatty food

Answer

Early menopause

Answer

Smoking

Answer

Multiple sexual partners

Breast Surgery — MCQs

Breast Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?